HCM
CDMO

Hollencrest Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Hollencrest Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8
Closed -$99 – 1263
2024
Q4 		$99 Hold
8
– – ﹤0.01% 1141
2024
Q3 		$91 Hold
8
– – ﹤0.01% 1081
2024
Q2 		$57 Hold
8
– – ﹤0.01% 1070
2024
Q1 		$54 Hold
8
– – ﹤0.01% 1062
2023
Q4 		$52 Hold
8
– – ﹤0.01% 1022
2023
Q3 		$76 Hold
8
– – ﹤0.01% 1047
2023
Q2 		$112 Hold
8
– – ﹤0.01% 1089
2023
Q1 		$150 Hold
8
– – ﹤0.01% 1100
2022
Q4 		$110 Buy
+8
New +$123 ﹤0.01% 1108

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hollencrest Capital Management's CDMO Position: Q1 2025 in Review

Hollencrest Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 8 shares — an estimated $99 sold.

Hollencrest Capital Management first reported a position in CDMO in Q4 2022 and held it in 9 quarters. The position peaked at $150 in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Hollencrest Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Hollencrest Capital Management sold 8 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $99.
  • Hollencrest Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2022 and held it in 9 quarters.
  • Hollencrest Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $150 in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Hollencrest Capital Management's 13F filing for Q1 2025, filed 5 May 2025.